Supplements Last reviewed: August 24, 2026

Is ashwagandha safe to take?

Moderate Evidence
Confidence Score 68%
⚖️

IT DEPENDS

Ashwagandha is generally safe for most healthy adults when taken at standard doses (300-600mg/day) for up to 3 months. However, rare liver injury cases have been reported, and it should be avoided during pregnancy and by those with thyroid conditions.

The Verdict

Ashwagandha is generally safe for most healthy adults when taken at standard doses (300-600mg/day) for up to 3 months. However, rare liver injury cases have been reported, and it should be avoided during pregnancy and by those with thyroid conditions.

What the Evidence Shows

Ashwagandha (Withania somnifera) has a long history of traditional use and has been studied in numerous clinical trials. Most RCTs report mild or no adverse effects at doses up to 600mg/day for 8-12 weeks. Common side effects include mild GI upset, drowsiness, and headache. However, the FDA and international regulators have documented rare cases of liver injury (hepatotoxicity), prompting safety warnings in some countries. The herb can stimulate thyroid function, making it risky for those with hyperthyroidism or on thyroid medication. It may also lower blood sugar and blood pressure, potentially interacting with diabetes and hypertension medications. Pregnant women should avoid it due to potential abortifacient effects observed in animal studies. Long-term safety data beyond 3 months is limited.

Evidence Quality

3

Meta-Analyses

15

RCTs

8

Observational

Important Caveats

  • ⚠️ Rare cases of liver injury (hepatotoxicity) have been reported to regulators worldwide
  • ⚠️ Can stimulate thyroid function — avoid if you have hyperthyroidism or take thyroid medication
  • ⚠️ May lower blood sugar and blood pressure — use caution with diabetes or BP medications
  • ⚠️ Not safe during pregnancy due to potential abortifacient effects
  • ⚠️ Long-term safety data beyond 3 months is limited
  • ⚠️ Quality varies widely between brands — contaminants have been found in some products

Population Studied

Healthy adults in RCTs lasting 4-12 weeks; post-marketing surveillance data from general population

Dosage

Doses of 300-600mg/day of standardized extract appear safe for most adults; higher doses increase risk of side effects

Duration

Most safety data comes from trials lasting 8-12 weeks; long-term use beyond 3 months is less studied

Supporting Studies (3)

Safety and clinical effectiveness of Withania somnifera root extract

RCT

Raut AA, Rege NN, Tadvi FM, et al. · Journal of Ayurveda and Integrative Medicine (2012)

In a dose-escalation study (750-1250mg/day), ashwagandha was well tolerated with no serious adverse events. Mild side effects included increased appetite and libido.

View paper (DOI) →

A systematic review of the safety of ashwagandha

Meta-Analysis

Tandon N, Yadav SS. · Journal of Ethnopharmacology (2020)

Review of 69 studies found ashwagandha generally well-tolerated with mild adverse effects (GI upset, drowsiness) at doses up to 1000mg/day.

View paper (DOI) →

Efficacy and tolerability of ashwagandha root extract in the elderly for improvement of memory

RCT

Choudhary D, Bhattacharyya S, Bose S. · Journal of Dietary Supplements (2017)

600mg/day for 8 weeks in elderly subjects showed no clinically significant adverse events; tolerability was comparable to placebo.

View paper (DOI) →

Contradicting Studies (2)

Ashwagandha-associated liver injury: A case series from Iceland and worldwide

Observational

Björnsson HK, Björnsson ES, Avula B, et al. · Liver International (2020)

Reported 5 cases of liver injury in Iceland linked to ashwagandha supplements, with patterns suggesting idiosyncratic drug-induced liver injury.

Why this disagrees:

While rare, these documented liver injury cases indicate ashwagandha is not universally safe. The mechanism appears idiosyncratic (unpredictable individual reactions) rather than dose-dependent.

View paper (DOI) →

Herbal hepatotoxicity: a growing concern

Observational

Navarro VJ, Khan I, Björnsson E, et al. · Hepatology (2017)

Ashwagandha was identified among herbal supplements associated with liver injury in the Drug-Induced Liver Injury Network registry.

Why this disagrees:

Population-level surveillance shows a small but real risk of liver injury that was not detected in controlled trials with limited participants.

View paper (DOI) →
Share:
Was this helpful?

Related Claims

💊 Related Supplements

More in Supplements

View all →